SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ciphergen Biosystems(CIPH):

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (482)3/24/2007 12:48:50 PM
From: tuck   of 510
 
[In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra]

>>J Proteome Res. 2007 Mar 21; [Epub ahead of print]

In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra.

Ekblad L, Baldetorp B, Ferno M, Olsson H, Bratt C.

Department of Oncology, Lund University, Se-221 85, Lund, Sweden.

SELDI-TOF MS is a mass spectrometric technique which has been extensively used for biomarker discovery. In this study, we show that in-source decay is an important source for the generation of additional spectral peaks with this technique, both for pure proteins and proteins in serum samples. Thus, SELDI-TOF MS could be used to gain sequence information from proteins, but the results also question the uncritical use of SELDI-TOF MS as a general method for the detection of biomarkers.<<

Not sure what these folks mean by "in-source decay," but it sounds as though sample prep and calibration aren't the only issues for getting accurate spectra. Sigh.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext